SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 13, 2012
(Exact name of registrant as specified in its charter)
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
(b) On December 13, 2012, Kenneth W. Freeman elected to conclude his tenure as Chairman of the Board of Directors of Accellent Inc. (the Board). Mr. Freeman will remain a member of the Board.
(d) On December 13, 2012 the Board appointed Donald J. Spence, the Companys President and Chief Executive Officer and a member of the Board, as Chairman of the Board. Mr. Spence will continue in his role as the Companys President and Chief Executive Officer.
On December 13, 2012 the Board appointed Justin Sabet-Peyman as a member of the Board. Mr. Sabet-Peyman joined Kohlberg Kravis Roberts & Co. L.P. (KKR) in 2008 and is a member of the Health Care industry team within KKRs Private Equity platform. KKR designated Mr. Sabet-Peyman for appointment to the Board pursuant to a Stockholders Agreement, dated as of November 16, 2005, among Accellent Holdings Corp., our parent company, an affiliate of KKR and certain affiliates of Bain Capital.
Prior to joining KKR, Mr. Sabet-Peyman worked at McKinsey & Company where he served private equity and corporate clients. Mr. Sabet-Peyman received his B.S. and M.S. from Stanford University where he graduated as the Henry Ford II Scholar of the School of Engineering and was a Mayfield Fellow.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.